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Abstract 
Passive transfer of colostrum immunoglobulins from cow to newborn is extremely important because calves under 5 
weeks of age do not have active immunity and colostrum antibodies are the only source of immunoglobulins to protect 
calves from infectious diseases immediately after birth. One of the most common causes of calf death is acute neonatal 
diarrhea caused by pathogens such as rotavirus, coronavirus and Escherichia coli. In the first weeks of life, calves 
acquire maternal antibodies from colostrum and milk can have a local protective effect against intestinal 
enteropathogens. Vaccination of pregnant cows reduces the morbidity and mortality rates of the calf. Vaccination of 
cows even in the early stages of pregnancy (6 months before calving) can provide passive protection in newborn calves 
against etiological agents such as enterotoxigenic Escherichia coli. Previous studies have shown that continuous 
administration of colostrum from immunized cows prevents severe diarrhea and mortality in calves. In North America 
and Europe, various vaccines against neonatal calf diarrhea have been developed to increase antibody titers in 
colostrum and cow's milk. However, there are not many studies on maternal vaccination to protect against diarrhea in 
calves in Romania. In this article we have detailed the results of a field study on improving passive immunity in calves 
by administering a multipurpose maternal vaccine available in Europe. 
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Introduction 
Neonatal diarrhea mainly affects calves under the age of 4 weeks. It is characterized by 
diarrhea that leads to dehydration and acidosis, which can have systemic consequences and can 
lead to death [5]. More than 50% of all cases of neonatal diarrhea occur in the first week of life and 
only 15% occur after the second week of life [4]. Calf loss, disease management and health 
consequences, growth rate and reproductive potential of surviving calves can lead to significant 
economic loss [1, 5]. 
The main infectious agents causing diarrhea, especially in calves under 12 days of age, are 
bovine rotavirus (BoRV), bovine coronavirus and enterotoxigenic Escherichia coli (ETEC), but 
other pathogens may also be responsible for this disease [1 , 4, 5]. The good part is that vaccines 
against some of the most common pathogens responsible for this disease are available on the 
market. [2. 3] 
The aim of this study was to evaluate the titer of specific BoRV, BoCV and E.coli F5 (K99) 
antibodies in the serum of pregnant cows, in colostrum and in the serum of newborn calves in order 
to highlight the immune response in cows and the passive transfer in calves. 
 
Material and methods 
In order to carry out the study, 2 experimental groups were established: the control group 
(M), to which no specific prophylaxis method against bovine rotavirus (BoRV), bovine coronavirus 
and Escherichia coli was applied and the experimental group (E) which was immunized with a 
trivalent Rotavec ™ Corona vaccine, MSD Animal Health, within 220-230 days of gestation. Each 
group consisted of 20 pairs of cow-calves from which 104 serum samples and 40 colostrum 
samples were collected between November 2019 - December 2019. In group E, 2 twin calvings 
were registered. Blood samples were collected from cows at 21 days post-vaccination, respectively 
between 241-251 days of gestation, and colostrum samples were collected immediately after 
calving. Calves received a dose of 4 liters of fresh colostrum harvested from their mothers in the 




first hour of life and blood samples were taken before an after colostrum consumption at 24 hours 
of age. 
Specific antibodies were detected using the competition enzyme immunoassay kits ELISA 
Bovine Rotavirus BIO-X Diagnostics, ELISA Coronavirus BIO-X Diagnostics, and ELISA 
blocking E. coli F5 (K99) BIO-X Diagnostics. The analyzes were performed in the Immunology 
laboratory of FMV Iaşi and the descriptive statistical data and intra-group comparisons were 
performed using the IBM SPSS Statistics Subscription program. 
 
Results and discussions 
 In the Figure 1 are represented graphically the mean values of bovine anti-rotavirus 
antibodies (BoRV), expressed as percent inhibition (PI%). It can be seen that the PI% of cow serum 
antibodies - colostrum antibodies - calf serum antibodies have higher values in group E. The level 
of anti-rotavirus antibodies in the serum of pregnant cows in group E shows a significant difference 
compared to group M, in group E registering an average of 77% PI, compared to 41.5% PI in group 
M (p value <0.001). Increased serum antibody titer in group E cows resulted in a higher synthesis 
of specific antibodies in colostrum (79.3% PI). In the serum of calves from group E there is an 
average of 94.4% PI and in the group M there was an average of 59%. The difference between the 
averages from the 2 groups is statistically significant with a p value <0.001. 
 
 
Fig. 1 – Graph of mean values of BoR expressed as percent inhibition measured with 
competitive ELISA from pregnant cow sera, colostrum and calf sera 
  
In Figure 2 are represented graphically the mean values of bovine anti-coronavirus 
antibodies (BoRV), expressed as percent inhibition (PI%). As in the case of the analysis of anti-
rotavirus antibodies, it can be observed that in group E the level of anti-coronavirus antibodies in 
the serum of pregnant cows increased considerably compared to group M, in group E registering 
an average of 96.2% PI, compared to of 32.6% PI in group M (p value <0.001). Elevated serum 
antibody levels in group E cows resulted in a high level of synthesis of specific antibodies in 
colostrum (98.9% PI). An average of 97.3% PI was recorded in the serum of calves from group E, 
and an average of 32.6% PI was recorded in the group M. The difference between the averages of 
the 2 groups is statistically significant with a p value <0.001. 





Fig. 2 – Graph of mean values of BoCV expressed as inhibition percentages measured by 
competitive ELISA from pregnant cow sera, colostrum and calf sera 
  
The values of anti-E. coli F5 (K99) antibodies, expressed as percent inhibition measured 
with ELISA blocking in the sera of pregnant cows and the sera of calves are plotted in Figure 3. In 
group M, both in the serum of pregnant cows and in the serum of calves, a minimal presence of 
anti-E.coli F5 (K99) antibodies was detected, with an average of 0.3% PI cows and 0.2% PI calves, 
respectively. The differences between group E and group M are statistically significant (p <0.001), 
in group E registering an average of 90.9% PI in the case of pregnant cows serum and 97.4% PI in 
the case of calves serum. 
 
 
Fig. 3 – Graph of mean values of anti-E.coli F5 antibodies (K99), expressed as 
percentages of inhibition measured by competitive ELISA in pregnant cows and calves 
 
The calf has an essential feature in terms of immunology: the titer of antibodies at birth is 
zero, during intrauterine life the transfer of antibodies by transplacental route from mother to fetus 
is zero. Consequently, it is born without adequate humoral immunity and is totally dependent on 
passive transfer via colostrum. To test this hypothesis, blood samples were collected from calves 
in group E before colostrum administration and 24 hours after administration to show the level of 











Specific antibodies in calf serum before and after colostrum, expressed as% inhibition measured 







Antibody values expressed in PI% 
BoRV, strain UK-Compton, serotype 
G6 P5 (inactivated) 
BoCV 
strain Mebus (inactivated) 







































(24 h life) 
 0 79,3 94,4 0 96,4 97,3 0 97,4 
SE 0 6,4 1,1 0 1,8 1,0 0 0,9 
Median 0 89,2 95,1 0 98,9 99,1 0 98,7 
SD 0 20,3 3,7 0 5,8 3,5 0 3,2 
Min. 0 35,0 88,3 0 80,2 89,7 0 88,5 
Max. 0 97,9 98,5 0 99,1 99,2 0 99,1 
CI 95% 0 14,5 2,3 0 4,2 2,2 0 2 
 
The presence of bovine anti-rotavirus, anti-bovine coronavirus or anti-E.coli F5 (K99) 
antibodies was not detected in the 22 serum samples collected before colostrum, which highlights 
the importance of colostrum administration in newborn calves for passive immune transfer of anti-
infective specific immunoglobulins. 
 
Conclusion  
Because rotavirus and coronavirus infections are endemic in cattle, most adult cows have 
been infected naturally. The sustained response of antibodies found in the serum and colostrum of 
cows in group M is most likely due to such infectious exposure. Also, the immune response of 
group E cows may be due to a primary infectious exposure prior to systemic vaccination, but 
vaccination causes a marked increase in specific serum antibody levels. If in the case of rotavirus 
and bovine coronavirus were detected after analysis titers of maternal antibodies synthesized 
following active infections (group M), in the case of anti-E.coli F5 antibodies (K99) in the study 
group they were almost nonexistent. The obtained results showed that by the active immunization 
of cows in the last gestation period the specific antibody titers increased significantly in group E 
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